Skip to main content

Approach to Narrow Complex Tachycardia

 



Approach to Narrow Complex Tachycardia (NCT)


Narrow Complex Tachycardia (NCT) refers to any tachyarrhythmia (heart rate >100 bpm) with a QRS duration <120 ms on the ECG. It indicates that ventricular activation is occurring via the normal His–Purkinje system, meaning the origin of the rhythm is at or above the AV node. A systematic approach helps identify the underlying mechanism, guide acute management, and prevent recurrence.


1️⃣ Step 1: Confirm It’s a Narrow Complex Tachycardia


Before labeling it NCT:


QRS <120 ms (3 small boxes) — confirms supraventricular origin.


Regular vs. Irregular rhythm — key to differential diagnosis.


Rate — often 150–250 bpm for re-entrant tachycardias; <150 for sinus tachycardia or atrial flutter with block.



Also exclude:


Artifact or sinus tachycardia due to secondary causes (fever, anxiety, hypovolemia, thyrotoxicosis, etc.).

---

2️⃣ Step 2: Classify by Rhythm Regularity


A. Regular Narrow Complex Tachycardia


Possible causes:


Sinus tachycardia

Atrioventricular Nodal Reentrant Tachycardia (AVNRT)

Atrioventricular Reentrant Tachycardia (AVRT, e.g. Orthodromic WPW)

Atrial Tachycardia

Junctional Tachycardia


B. Irregular Narrow Complex Tachycardia


Possible causes:

Atrial fibrillation (AF)

Atrial flutter with variable block

Multifocal atrial tachycardia (MAT)

---


3️⃣ Step 3: ECG Clues to Differentiate Regular NCTs

Clearly define:

Onset/Termination Gradual Sudden Sudden Sudden or gradual

P wave visibility Normal upright in II, before QRS Often hidden in QRS or short RP Retrograde P after QRS (RP < PR) P before QRS (RP > PR)

Rate (bpm) <180 140–250 150–250 100–250

Mechanism Enhanced automaticity Reentry within AV node Reentry via accessory pathway Focal atrial origin


Mnemonic:

Short RP = AVNRT/AVRT

Long RP = Atrial tachycardia or sinus tachycardia


4️⃣ Step 4: Acute Management Strategy


1. Assess Stability

Unstable (hypotension, chest pain, pulmonary edema, altered consciousness) → Immediate synchronized DC cardioversion.

2. Stable Patients

Proceed systematically:

Step 1: Vagal Maneuvers

Carotid sinus massage (if no bruit), Valsalva maneuver, modified Valsalva (leg raise after strain).


Effective for AVNRT/AVRT by increasing vagal tone.


Step 2: Adenosine

6 mg rapid IV bolus → flush → if no response, 12 mg → repeat once if necessary.


Diagnostic and therapeutic.

Caution: Avoid in irregular NCT (possible AF with accessory pathway).



Step 3: Rate or Rhythm Control

If adenosine fails, consider verapamil, diltiazem, or beta-blockers (for AVNRT/AVRT).


For atrial tachycardia, focus on treating underlying cause (e.g. digitalis toxicity, hypoxia).

---


5️⃣ Step 5: Post-Conversion Evaluation


Once sinus rhythm is restored:

12-lead ECG — look for pre-excitation (delta wave) or P-wave morphology.


Echocardiography — assess structural heart disease.

Holter monitoring or EP study — if recurrent or uncertain mechanism.


6️⃣ Step 6: Long-Term Management


Recurrent AVNRT/AVRT: Catheter ablation is first-line definitive therapy with >95% success.


Atrial tachycardia: May require ablation or antiarrhythmic drugs.


Atrial fibrillation/flutter: Manage as per CHA₂DS₂-VASc score, anticoagulation, and rhythm/rate control strategy.


Address triggers: Caffeine, stress, stimulants, thyroid disease, etc.

---


7️⃣ Quick ECG Algorithm for NCT


1️⃣ Is it regular or irregular?

→ Regular → Step 2

→ Irregular → AF/flutter/MAT


2️⃣ P waves visible?

→ Yes → Sinus or atrial tachycardia

→ No → AVNRT or AVRT likely


3️⃣ RP vs PR?

→ Short RP → AVNRT/AVRT

→ Long RP → Atrial tachycardia/sinus tachycardia



---


πŸ” Key Takeaways


Narrow QRS = supraventricular origin.


Always assess stability first — treat unstable with cardioversion.


Adenosine is both diagnostic and therapeutic in regular NCT.


Ablation offers curative therapy for recurrent AVNRT/AVRT.


Never give AV nodal blockers in irregular pre-excited tachycardias (e.g. WPW + AF).

---


πŸ«€ Summary Table


Step Key Focus Action


1 Confirm NCT QRS <120 ms

2 Rhythm Regularity Regular vs Irregular

3 P wave & RP interval Differentiate AVNRT/AVRT/AT

4 Stability Cardioversion if unstable

5 Vagal & Adenosine First-line in stable

6 Long-term plan Identify mechanism + ablation




---


πŸ“š References


1. 2023 ESC Guidelines for the Management of Supraventricular Tachycardia



2. ACC/AHA/HRS Guidelines on the Management of Patients with Arrhythmias



3. UpToDate: "Overview of narrow QRS complex tachycardias"



---


πŸ”– Hashtags


#Cardiology #El

ectrophysiology #ECG #Tachycardia #AVNRT #AVRT #AtrialTachycardia #MedicalEducation #EPApproach

Comments

Popular posts from this blog

Brugada ECG vs Incomplete Right Bundle Branch Block (iRBBB)

Brugada ECG vs Incomplete Right Bundle Branch Block (iRBBB) Why this differentiation matters Brugada pattern is a malignant channelopathy associated with sudden cardiac death, while incomplete RBBB is usually a benign conduction variant. Mislabeling Brugada as iRBBB can be fatal; overcalling iRBBB as Brugada can lead to unnecessary anxiety and ICD implantation. --- 1. Basic Definitions Brugada ECG Pattern Primary repolarization abnormality Genetic sodium-channel disorder Characteristic ST-segment elevation in V1–V3 Risk of ventricular fibrillation and sudden death Incomplete RBBB (iRBBB) Depolarization abnormality Delay in right ventricular conduction Common in healthy individuals Usually asymptomatic and benign --- 2. ECG Morphology: Side-by-Side Comparison QRS Duration Brugada: QRS usually <120 ms iRBBB: QRS <120 ms, but with RBBB morphology --- V1–V2 Pattern (Key Differentiator) Brugada Pseudo-RBBB appearance ST elevation ≥2 mm ST segment is coved or saddleback Terminal QRS bl...

π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š

 π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š in  Patient with AF and acute IS/TIA European Heart Association Guideline recommends: • 1 days after TIA • 3 days after mild stroke • 6 days after moderate stroke • 12 days after severe stroke Early anticoagulation can decrease a risk of recurrent stroke and embolic events but may increase a risk of secondary hemorrhagic transformation of brain infarcts.  The 1-3-6-12-day rule is a known consensus with graded increase in delay of anticoagulation between 1 and 12 days after onset of ischemic stroke or transient ischemic attack(TIA), according to neurological severity based on European expert opinions. However, this rule might be somewhat later than currently used in a real-world practical setting.

Acute Treatment of Hyperkalemia

Acute Treatment of Hyperkalemia – A Practical, Bedside-Oriented Guide Hyperkalemia is a potentially life-threatening electrolyte abnormality that demands prompt recognition and decisive management. The danger lies not only in the absolute potassium value but in its effects on cardiac conduction, which can rapidly progress to fatal arrhythmias. Acute treatment focuses on three parallel goals: stabilizing the cardiac membrane, shifting potassium into cells, and removing excess potassium from the body. Understanding this stepwise approach helps clinicians act quickly and rationally in emergency settings. Why Hyperkalemia Is Dangerous Potassium plays a key role in maintaining the resting membrane potential of cardiac myocytes. Elevated serum potassium reduces the transmembrane gradient, leading to slowed conduction, ECG changes, ventricular arrhythmias, and asystole. Importantly, ECG changes do not always correlate with potassium levels, so treatment decisions should be based on clinical c...